A Redox-Active Ionic Liquid Surface Treatment for Healing CsPbBr3 Nanocrystals
Source abstract
Abstract
High Resolution Image Download MS PowerPoint Slide Additive engineering of lead halide perovskites has been a successful strategy for reducing a variety of deleterious defect types. Ionic liquids (ILs) are a unique group of such additives that have been used to passivate halide vacancies in both bulk lead halide perovskites and their colloidal nanocrystal analogues. Herein, we expand the types of defects that can be addressed through IL treatments in CsPbBr 3 nanocrystals with a novel phosphonium tribromide IL that heals metallic lead surface defects through redox chemistry. This new type of surface treatment leads to a significant increase in PLQY and outperforms equivalent treatments with non-redox-active bromide ILs. Such redox-active ligands widen the scope of defect types that can be addressed in semiconductor nanocrystals.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Perovskite Materials and Applications · Quantum Dots Synthesis And Properties · Solid-state spectroscopy and crystallography
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemistry, University of Southern California, Los Angeles, California 90089, United States
Department of Chemical Research Support, Weizmann Institute of Science, Rehovot 76100, Israel
Department of Molecular Chemistry and Materials Science, Weizmann Institute of Science, Rehovot 76100, Israel
Funding
United States-Israel Binational Science Foundation
References (30)
Show source-provided references
1. 10.1021/accountsmr.1c0015410.1021/accountsmr.1c00154 ↗
2. 10.1021/acsenergylett.0c0269610.1021/acsenergylett.0c02696 ↗
3. 10.1038/nenergy.2016.14910.1038/nenergy.2016.149 ↗
4. 10.1002/anie.20140974010.1002/anie.201409740 ↗
5. 10.1039/C9CP00414A10.1039/C9CP00414A ↗
6. 10.1039/C8CS00853A10.1039/C8CS00853A ↗
7. 10.1002/adma.20170627310.1002/adma.201706273 ↗
8. 10.1002/admi.20180088210.1002/admi.201800882 ↗
9. 10.1021/acs.chemrev.7b0024610.1021/acs.chemrev.7b00246 ↗
10. 10.1021/acssuschemeng.2c0766110.1021/acssuschemeng.2c07661 ↗
11. 10.1039/D0NR00579G10.1039/D0NR00579G ↗
12. 10.1063/5.014791810.1063/5.0147918 ↗
13. 10.1021/acsenergylett.4c0255710.1021/acsenergylett.4c02557 ↗
14. 10.1021/acs.chemmater.6b0484110.1021/acs.chemmater.6b04841 ↗
15. 10.1021/acsenergylett.8b0166910.1021/acsenergylett.8b01669 ↗
16. 10.1002/anie.20180691610.1002/anie.201806916 ↗
17. 10.1021/jacs.9b1339610.1021/jacs.9b13396 ↗
18. 10.1016/j.cej.2021.13279010.1016/j.cej.2021.132790 ↗
19. 10.1039/C8GC01061G10.1039/C8GC01061G ↗
20. 10.1039/C5CP06913K10.1039/C5CP06913K ↗
21. 10.1021/ic100869r10.1021/ic100869r ↗
22. 10.1021/nl504877910.1021/nl5048779 ↗
23. 10.1021/cm303361s10.1021/cm303361s ↗
24. 10.1039/C6CC01088A10.1039/C6CC01088A ↗
25. 10.1002/adfm.20180094510.1002/adfm.201800945 ↗
26. 10.1021/acsnano.1c0662410.1021/acsnano.1c06624 ↗
27. 10.1021/jacs.2c0263110.1021/jacs.2c02631 ↗
28. Bard A. J. · 1985
29. 10.1021/acs.chemmater.0c0453610.1021/acs.chemmater.0c04536 ↗
30. 10.1021/acs.nanolett.8b0056010.1021/acs.nanolett.8b00560 ↗